awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36831384-00FA6B7D-5EFD-481D-9D46-32EC7B62ACC1
Q36831384-00FA6B7D-5EFD-481D-9D46-32EC7B62ACC1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36831384-00FA6B7D-5EFD-481D-9D46-32EC7B62ACC1
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.
P2860
Q36831384-00FA6B7D-5EFD-481D-9D46-32EC7B62ACC1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36831384-00FA6B7D-5EFD-481D-9D46-32EC7B62ACC1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6a5e8f6ad0e6defccc48bb20c3e250ac9d8c518
P2860
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.